BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases

Abstract Background BCR::ABL1-like acute lymphoblastic leukaemia (BCR::ABL1-like ALL) is characterized by inferior outcomes. Current efforts concentrate on the identification of molecular targets to improve the therapy results. The accessibility to next generation sequencing, a recommended diagnosti...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Anna Płotka, Anna Przybyłowicz-Chalecka, Maria Korolczuk, Zuzanna Kanduła, Błażej Ratajczak, Jolanta Kiernicka-Parulska, Anna Mierzwa, Katarzyna Godziewska, Małgorzata Jarmuż-Szymczak, Lidia Gil, Krzysztof Lewandowski
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2023-07-01
Serie:	Molecular Cytogenetics
Ämnen:	BCR::ABL1-like acute lymphoblastic leukemia Cytogenetic analysis Molecular characteristic Molecular-targeted therapy
Länkar:	https://doi.org/10.1186/s13039-023-00645-1
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!